How To Choose Microfiltration Or Ultrafiltration membranes cassettes?
Apr 30, 2026| Microfiltration (MF) - Precise particulate control for biopharma processes
Microfiltration membranes with 0.1–0.5 µm pores to remove suspended solids, sediments and larger microorganisms, delivering clear, low-turbidity process streams. In biopharmaceutical manufacturing MF is ideal for:
- Clarifying cell culture supernatant and fermentation broths
- Protecting downstream equipment by reducing particulate load and fouling
- Acting as a primary barrier in water-for-process and utility water systems
Key benefits: high throughput, low operating pressure, extended life of downstream membranes. Note: MF does not remove dissolved salts, low‑molecular‑weight organics or reliably clear viruses-use as part of a multi‑stage purification train.
Ultrafiltration (UF) - Concentration and fine‑particle removal with molecular selectivity
Ultrafiltration features tighter pores (~0.01–0.1 µm; MWCO expressed in kDa) to retain bacteria, colloids and larger biomolecules. UF is commonly used for:
- Protein concentration and buffer exchange (diafiltration)
- Advanced clarification of fermentation and cell culture effluents
- Reducing colloidal and high‑molecular‑weight impurities prior to final purification
- Supporting virus‑reduction workflows when combined with validated virus‑removal filters
Key benefits: effective macromolecule retention, scalable flux rates, lower energy compared with RO. UF complements-rather than replaces-validated sterilizing or virus‑removal steps.
Why integrate MF and UF in biopharma plants?
- Optimized multi-stage protection: MF reduces solids load and protects UF/sterilizing filters, improving uptime and lowering lifecycle cost.
- GMP and validation readiness: membranes available in pharmacopeia‑grade materials that support CIP/SIP, integrity testing and routine process validation.
- Flexible deployment: scalable modules for pilot to commercial production, compatible with protein, vaccine and sterile drug processes.
- Regulatory & operational highlights
Choose membrane materials and configurations that support CIP/SIP and validated integrity tests.
Implement routine microbial, endotoxin and integrity monitoring to meet GMP expectations.
Use MF/UF as part of a validated, multi‑barrier strategy for product safety and process robustness.
Get started
Talk to our filtration specialists to design an MF/UF solution tailored to your biopharma application-clarification, concentration, or upstream/downstream protection.

